Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


MPs say no reason to change flu vaccine procurement system

A report from the House of Commons Science and Technology Committee has declined to support change to the flu vaccine procurement system. 

Vaccine and medication supplies


Community pharmacists have reported shortages of adjuvanted trivalent flu vaccine — but a government report says there is no reason to change the current procurement system

MPs on the House of Commons Science and Technology Committee say they have confidence in the current flu vaccination procurement system and there is no reason for reform, despite numerous reports of supply shortages.

In a report published on 16 October 2018, the committee said it was “reassured” that action has been taken to tackle shortages where they exist during the current flu season, and said that they “see no reason why this arrangement should change”.

Its publication coincides with community pharmacists telling The Pharmaceutical Journal that they were having to turn patients away as a result of problems acquiring sufficient supplies of the adjuvanted trivalent (aTIV) flu vaccination.

The problem has prompted the Pharmaceutical Services Negotiating Committee (PSNC) to produce a leaflet for community pharmacists to give to patients, explaining the reason for vaccine shortages and why it is still important to return at a later date for the immunisation.

This is the first year that the aTIV vaccination has been used, following a recommendation from the Joint Committee on Vaccination and Immunisation that patients aged over 65 years should receive it. The vaccine, Fluad, is manufactured solely by Seqirus. Following negotiations with the PSNC, the British Medical Association and NHS England, delivery of the vaccine to pharmacies and GP practices will be staggered throughout October and December 2018.

MPs are convinced that effective systems are already in place to tackle stock supply problems and that no new action is needed.

Their report pointed out that any shortages created by failure to order supplies or where demand exceeds current stock can be dealt with at a local level, as vaccine stocks can be shared between community pharmacies and local surgeries within a locality if necessary.

The commitee’s view followed evidence heard during the inquiry from Paul Cosford, director for health protection and medical director at Public Health England, who was also reluctant to see change.

He told the inquiry: “We would have to think carefully about any changes in the system of procurement because the last thing we want to do is to remove the incentives that get our programmes to the best possible level.

“If we were to change the procurement system, we would have to be very cautious about making sure that was done with the complete engagement and support of GPs and that the systems to value their input were absolutely there.”

In its report, the committee also expressed “shock” at the low uptake of the vaccine by staff working in care homes in the 2017/2018 flu season, which reached a maximum of 25%.

Norman Lamb, chair of the committee, said: “Some of our most vulnerable people are living in care homes and more must be done to protect them.”

The committee said it wanted a 100% vaccination target introduced for care home staff and suggested that Care Quality Commission inspectors should consider vaccination uptake rates as part of their inspection programme of care providers.

The MPs were also concerned about the variation in vaccination rates among hospital staff. They felt that healthcare professionals had a duty to be vaccinated and wanted the government to consider making the vaccination mandatory for some health workers.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205622

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Vaccine and medication supplies

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.